A potential transaction could value the company at about $30 billion, and could attract private-equity bidders, said the person, who asked not to be named because the information isn’t yet public. The process is still at an early stage.
A Goldman representative declined to comment while an official at Medline didn’t immediately respond to a voice mail after office hours.
Dow Jones
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.